Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025271
Filing Date
2019-05-10
Accepted
2019-05-10 16:11:03
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520699_10q.htm 10-Q 260777
2 EXHIBIT 3.1 tv520699_ex3-1.htm EX-3.1 43610
3 EXHIBIT 31.1 tv520699_ex31-1.htm EX-31.1 11655
4 EXHIBIT 31.2 tv520699_ex31-2.htm EX-31.2 11587
5 EXHIBIT 32 tv520699_ex32.htm EX-32 7317
12 GRAPHIC tv520699_img1.jpg GRAPHIC 75227
  Complete submission text file 0001144204-19-025271.txt   3788531

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abeo-20190331.xml EX-101.INS 1115196
7 XBRL TAXONOMY EXTENSION SCHEMA abeo-20190331.xsd EX-101.SCH 23756
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20190331_cal.xml EX-101.CAL 30570
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20190331_def.xml EX-101.DEF 173420
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20190331_lab.xml EX-101.LAB 202397
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20190331_pre.xml EX-101.PRE 201395
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 19815009
SIC: 2834 Pharmaceutical Preparations